Cardiovascular Therapy Agents Use

    Basic Details
    Date Posted
    Friday, September 13, 2013
    Status
    Complete
    Medical Product
    acebutolol HCL
    aliskiren hemifumarate
    ambrisentan
    amlodipine besylate
    atenolol
    betaxolol HCL
    bosentan
    captopril
    carvedilol
    conivaptan HCL
    diltiazem HCL
    eprosartan mesylate
    indapamide
    labetalol HCL
    lisinopril
    metoprolol succinate
    metoprolol tartrate
    metoprolol/hydrochlorothiazide
    nadolol
    nimodipine
    perindopril erbumine
    propafenone HCL
    trandolapril
    triamterene
    Description

    Summary table assessment of the use of 24 selected cardiovascular therapies including, Acebutolol HCL, Aliskiren Hemifumarate, Amlodipine Besylate, Ambrisentan, Atenolol, Betaxolol HCL, Bosentan, Captopril, Carvedilol, Conivaptan HCL, Diltiazem HCL, Eprosartan Mesylate, Indapamide, Labetalol HCL, Lisinopril, Metoprolol Succinate, Metoprolol Tartrate, Metoprolol/Hydrochlorothiazide, Nadolol, Nimodipine, Perindopril Erbumine, Propafenone HCL, Trandolapril, and Triamterene. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.Summary tables are precompiled stratified counts. Queries were executed in July 2012. This report includes data from 16 Data Partners.

    This document is an Excel spreadsheet that includes multiple layers of data configured using pivot tables. If you do not have Excel, click here to obtain a free version of Microsoft’s Excel Viewer.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2000 - 2011
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All children 14 years of age and younger
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)